# Screening Tool to Identify the Dominant Pain Mechanism in Cancer Survivors: PainsCan

> **NCT03981809** · — · COMPLETED · sponsor: **Universitaire Ziekenhuizen KU Leuven** · enrollment: 92 (actual)

## Conditions studied

- Cancer Survivors
- Cancer Pain

## Interventions

- **DIAGNOSTIC_TEST:** Diagnostic test ("PainsCan") for the identification of the dominant pain mechanisms in cancer survivers with persistent pain

## Key facts

- **NCT ID:** NCT03981809
- **Lead sponsor:** Universitaire Ziekenhuizen KU Leuven
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-13
- **Primary completion:** 2022-12-30
- **Final completion:** 2022-12-30
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2023-08-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03981809

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03981809, "Screening Tool to Identify the Dominant Pain Mechanism in Cancer Survivors: PainsCan". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT03981809. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
